-- Days : -- HRS : -- MIN : -- SEC
Register Now →
Commentary|Videos|July 2, 2026

3 Considerations for Oncology Pharmacy Care Delivery: Minhee Kang, PharmD

Fact checked by: Brooke McCormick

Minhee Kang, PharmD, discusses 3 key considerations for oncology pharmacists to improve treatment safety, patient education, and care delivery.

Pharmacists’ role in health care management and delivery has become more involved in oncology workflow and direct patient care, but how they operate within these systems was a key point during the Washington, DC, Institute for Value-Based Medicine® (IVBM) event.

The IVBM on June 25, 2026, was composed of multiple panels over a broad range of oncology specialties. One panel discussion, “Advancing Pharmacy Operations & Workflows in Oncology,” allowed pharmacists, including Minhee Kang, PharmD, a manager of oncology and research pharmacy at MedStar Georgetown University Hospital, to compare their roles between clinical community oncology practices and academic centers.

In an interview with The American Journal of Managed Care®, Kang explained that a key role of pharmacists is to manage toxicities associated with newer oncology therapies. She highlighted 3 important factors pharmacists should consider when delivering these therapies.

“The first thing we wanted to do was build a treatment therapy plan to ensure that all those parameters of supportive care are already built in,” Kang said.

The second consideration is lab parameters, essentially confirming that patients and the pharmacists adhere to the prescription guidelines. The third consideration is in the implementation of the infusion clinic, she explained.

“Her or his role will actually be going to the patient and seeing and asking the patient what the treatment is and if that patient understands what kind of treatment the patient is getting and what side effects the patient would expect,” Kang said.

Ensuring that patients understand their treatment plan helps to ease patient anxiety and reduce the risk of toxicities and potentially improve adherence, she explained.

“We see the benefit of double education even though the patient comes to the clinic after being educated by a nurse navigator or providers,” Kang said. “But having a pharmacist on that side as well to give another education is very helpful to prevent possible toxicity in the future.”